Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Global ADME-Toxicology Testing Market 2016-2024 with Profile of 69 Key and Niche Players - Research and Markets

This image opens in the lightbox

News provided by

Research and Markets

21 Jun, 2017, 12:00 GMT

Share this article

Share toX

Share this article

Share toX

DUBLIN, June 21, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "ADME-Toxicology Testing - Global Strategic Business Report" report to their offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets.

This report analyzes the worldwide markets for ADME-Toxicology Testing in US$ by the following Segments: Toxicology Testing (In-Vivo, In-Vitro), and ADME Testing. Market data and analytics are derived from primary and secondary research.

The report profiles 69 companies including many key and niche players such as

  • ACEA Biosciences, Inc. (USA)
  • ADMEcell, Inc. (USA)
  • Agilent Technologies, Inc. (USA)
  • Albany Molecular Research, Inc. (USA)
  • Beckman Coulter, Inc. (USA)
  • BioreclamationIVT, LLC (USA)
  • Cerep SA (France)
  • CompuDrug International, Inc. (USA)
  • Cyprotex PLC. (UK)
  • CeeTox, Inc. (USA)
  • Dassault Systèmes Biovia Corp. (USA)
  • Eurofins ADME BIOANALYSES SAS (France)
  • Galapagos NV (Belgium)
  • Molecular Discovery Ltd. (UK)
  • MultiCASE, Inc. (USA)
  • Optivia Biotechnology (USA)
  • PerkinElmer, Inc. (USA)
  • Pharmaron, Inc. (USA)
  • Promega Corporation (USA)
  • Qualyst, Inc. (USA)
  • Simulations Plus, Inc. (USA)
  • Taconic Biosciences, Inc. (USA)
  • Takara Bio Europe AB (Sweden)
  • Tecan Group Ltd. (Switzerland)
  • Thermo Fisher Scientific, Inc. (USA)

Key Topics Covered:

1. OUTLOOK

  • ADME-Tox Testing Gains Traction
  • A Peek into the Impact of ADME-Tox Screening on New Drug Discovery
  • Current and Future Analysis
  • US and Europe Dominate, Asia-Pacific Lends Growth Momentum
  • Growth Momentum Shifts Away from In Vivo Technologies; In Vitro Technologies to Lead the Charge

2. INDUSTRY OVERVIEW

  • Pharma Industry Renews Focus on Cost Optimization
  • ADME-Tox Assays
  • Introduction of Early In Vitro ADMET Studies
  • Growing Prominence of Cell-based Assays in Drug Discovery and ADME Analysis
  • Major Types of Cell-Based HTS Assays for Drug Screening
  • CROs Expand Presence
  • Drug Discovery Outsourcing and Type of Services Outsourced
  • Changing Face of Drug Discovery Outsourcing Activity
  • M&A
  • Order of the Day

3. MARKET DYNAMICS

  • Current State of ADME-Tox Testing
  • Need for Better Models: A Major Factor Driving Innovation in the Market
  • Focus Shifts to Innovative Approaches
  • In Silico and In Vitro- the Way to Go
  • In Vitro Testing Systems and Its Relevance in Drug Development
  • Growing Inclination towards In-vitro Assays for Toxicology Studies
  • In Silico ADME-Tox Growing at a Fast Clip
  • Advantages of Using In Silico Approaches
  • Factors Hindering Growth
  • 3-D Tissue Bioassays to Enhance In Vitro Toxicity Testing
  • Increasing Use of Cell-Based Assays over Other Methods in Toxicity Testing
  • Rising Number of Drug Targets Surge Demand for Cell-Based Assays
  • Growing Focus on the Development of Reproducible and Robust Cell-based Assays
  • Functional Assays: An Effective Way of Predicting Specific Toxic Effects 

4. DRUG DISCOVERY & DEVELOPMENT

  • Drug Discovery and Development
  • Target identification
  • Target Validation
  • Lead Identification
  • Lead Optimization
  • Pharmaceuticals
  • R&D Value Chain
  • Pre-Clinical Testing
  • Clinical Trials
  • Clinical Trials
  • The Time Line
  • Drug Discovery Technologies
  • Innovation in Screening Guarantees Success for Drug Discovery Programs

5. PRODUCT OVERVIEW

  • ADME-Tox
  • An Introduction
  • Absorption
  • Distribution
  • Metabolism
  • Excretion
  • Toxicity
  • ADME-Tox Profiling
  • ADME-Tox Screening Technologies
  • ADME-Tox Parameters
  • Cell Based Assays
  • Liver Cell Based Assays
  • Intestinal Cell Based Assays
  • Kidney Cell Based Assays

6. PRODUCT INNOVATIONS/INTRODUCTIONS

  • Corning Adds Two New Products to ADME/Tox Lineup
  • Sovicell and 3B Pharmaceuticals Launch EScalate Assay Service
  • Lonza Launches Human and Animal Hepatocytes for Adme-Tox Testing
  • Cyprotex Launches Eight New Transporter Assays
  • Simulations Plus Rolls Out Version 8.0 of ADMET Predictor Software
  • Simulations Plus Launches Version 7.2 of ADMET Predictor Software
  • BioReliance® Unveils Select In Vitro ADME and Toxicology Testing Services
  • Cyprotex Releases SenCeeTox® Technology with Enhanced Capabilities
  • Cyprotex Expands In-House Drug Transporter Services
  • Cyprotex Launches KeratinoSens Service
  • Simulations Plus Introduces ADMET Predictor Version 7.1
  • Lena Biosciences Launches SeedEZ 3D Cell Culture Products
  • Sigma® Life Science to Introduce Genetically-Modified HepaRG Human Liver Cell Line

7. RECENT INDUSTRY ACTIVITY

  • Simulations Plus to Take Over DILIsym Services
  • Simulations Plus and Electrolab India Sign Distribution Deal
  • Simulations Plus Inks Distribution Deal with Quantum Bio Solutions for Korean Market
  • Cyprotex Moves to New Location in the UK
  • Pharmaron Takes Over Xceleron
  • Evotec Acquires Cyprotex
  • Endonovo Expands Cytotronics Platform for Toxicology Testing
  • Takara Bio Acquires Cellectis AB
  • WuXi PharmaTech Acquires XenoBiotic Laboratories
  • Merck KGaA to Take Over Sigma-Aldrich
  • Dassault Systèmes Acquires Accelrys
  • Organovo Collaborates with J&J for 3D Bioprinting Drug Discovery Research
  • Taconic and IVAL Enter into Agreement
  • Charles River to Acquire Galapagos' Argenta and BioFocus Service Divisions
  • Simulations Plus Signs 5-Year RCA with the US FDA
  • Simulation Plus Inks Distributor Agreement with RILD
  • Harlan CRS Enters into Strategic Alliance with Bertin Pharma
  • Pharmaron Receives GLP Certification from the CFDA for GLP Toxicology Facilities
  • Cyprotex Acquires CeeTox
  • Taconic Announces Name Change
  • Rosa & Co. Acquires Entelos Holdings' Consulting Service Business
  • Thermo Fisher Scientific Acquires Life Technologies

8. FOCUS ON SELECT PLAYERS

9. GLOBAL MARKET PERSPECTIVE

For more information about this report visit https://www.researchandmarkets.com/research/k5jd3s/admetoxicology

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.